Video

Dr. Diehl on the Unique Nature of Hodgkin's Lymphoma

Dr. Volker Diehl from the University of Cologne, Germany on the Unique Nature of Hodgkin's Lymphoma

Volker Diehl, MD, Professor of Medicine, Emeritus, University of Cologne, Germany, explains that Hodgkin's lymphoma is unique because the microenvironment contains a minority of tumors cells and an abundance of reactive cells.

This disease demonstrates an intelligent interaction between the microenvironment and the tumor cells. When treating Hodgkin's lymphoma is it necessary to kill all cells including the inert tumor cells and the not yet well-defined clonogenic cells that interact with the microenvironment.

Related Videos
Minoo Battiwalla, MD, MS
Cynthia X. Ma, MD, PhD
Jyoti Patel, MD
Leo I. Gordon, MD
Bertram Yuh, MD, MISM, MSHCPM
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the treatment goals in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss factors for picking intensive chemotherapy vs other regimens in acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss long-term data for CPX-351 in acute myeloid leukemia.